morning September 8, 2011，Shaanxi Provincial Industry and Information Department、Technology Department、Education Department and the "Eleventh Five -Year Plan" industry -university -research joint development achievement exhibition and 2011 trading conference hosted by the Education Department and the Industry, Graduate and Research Federation held at the Qujiang International Convention and Exhibition Center。Shaanxi Pharmaceutical Group Zhang Jian General Pharmacy participated in the opening ceremony as the main guest。The exhibition meeting aims to focus on showing the rich results achieved by the "11th Five -Year Plan" period of our province，Signing cooperation with the latest scientific and technological achievements of all parties in industry, university and research。According to the requirements of the Industry and Information stake sports betting appDepartment，Shaanxi Pharmaceutical Group participated in the exhibition conference，The exhibition area of ​​the group exhibition area has achieved the fruitful results of scientific research during the "11th Five -Year Plan" period、Joint Development Model of Industry, Studies and Research、Strong R & D strength and the "Twelfth Five -Year Plan" grand plan for fully display and publicize。

At the signing ceremony，Director Xiao Zhiqiang of R & D Center on behalf of Shaanxi Pharmaceutical Group and Xi'an Jiaotong University、Northwest University、Shaanxi Normal University、Shaanxi Medical College、Shaanxi Institute of Traditional Chinese Medicine、Shaanxi Provincial University Technology Transfer Center and other scientific research institutes signed the "Shaanxi Biopharmaceutical Industry and Research Innovation Alliance Cooperation Agreement"。The signing of the agreement laid stake betting appthe foundation for the establishment of Shaanxi Biomedical Industry and Research Innovation Alliance，Through the industry, research and research innovation alliance, it will promote the effective integration of the resources of the biomedical industry in Shaanxi，Promote talents、Technology、Organic combination of capital，Improve the core competitiveness of the group company，Promoting Shaanxi Biomedical Technology Innovation and Development。